We are live on
!
Find out more
OAM
Oberweis Asset Management Portfolio holdings
AUM
$3.39B
1-Year Est. Return
105.5%
This Fund
S&P 500
This Quarter
Est. Return
+8.75%
1 Year Est. Return
+105.5%
3 Year Est. Return
+311.52%
5 Year Est. Return
+632.9%
10 Year Est. Return
+11,604.3%
AUM
$550M
AUM Growth
+$52.4M
(+11%)
Cap. Flow
+$19.4M
Cap. Flow
% of AUM
3.53%
Top 10 Holdings %
Top 10 Hldgs %
52.39%
Holding
230
New
29
Increased
85
Reduced
59
Closed
34
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$47.5M |
| 2 |
uniQure
QURE
|
+$28.2M |
| 3 |
CACI
CACI
|
+$6.46M |
| 4 |
IPHI
INPHI CORPORATION
IPHI
|
+$4.67M |
| 5 |
ALTR
Altair Engineering Inc
ALTR
|
+$4.62M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MLNX
Mellanox Technologies, Ltd.
MLNX
|
+$33.8M |
| 2 |
GOOS
Canada Goose Holdings
GOOS
|
+$13.2M |
| 3 |
BEAT
BioTelemetry, Inc.
BEAT
|
+$8.78M |
| 4 |
CYBR
CyberArk
CYBR
|
+$5.02M |
| 5 |
Ligand Pharmaceuticals
LGND
|
+$4.83M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 39.64% |
| 2 | Consumer Staples | 13.57% |
| 3 | Technology | 13.22% |
| 4 | Industrials | 12.46% |
| 5 | Consumer Discretionary | 9.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLGX
176
DELISTED
Corelogic, Inc.
CLGX
| $273K | 0.05% |
6,530
+200
| +3% | +$8.16K |
|
177
Plexus
PLXS
$6.72B
| $269K | 0.05% |
4,600
+100
| +2% | +$5.77K |
|
|
LOGM
178
DELISTED
LogMein, Inc.
LOGM
| $265K | 0.05% |
3,600
+100
| +3% | +$7.73K |
|
179
Green Dot
GDOT
$743M
| $245K | 0.04% |
5,000
-80,460
| -94% | -$4.38M |
|
180
Newmont
NEM
$98.7B
| $242K | 0.04% |
6,299
+37
| +0.6% | +$1.25K |
|
181
BHP
BHP
$215B
| $235K | 0.04% |
4,541
| – | – |
|
182
Werner Enterprises
WERN
$2.24B
| $233K | 0.04% |
+7,500
| New | +$242K |
|
|
SLCA
183
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $219K | 0.04% |
17,109
| – | – |
|
184
McDonald's
MCD
$192B
| $218K | 0.04% |
+1,049
| New | +$208K |
|
185
Terex
TEX
$7.18B
| $217K | 0.04% |
6,900
+200
| +3% | +$6.14K |
|
186
Hanmi Financial
HAFC
$945M
| $216K | 0.04% |
+9,700
| New | +$215K |
|
187
Brink's
BCO
$4.88B
| $214K | 0.04% |
+2,630
| New | +$209K |
|
|
BNY
188
Bank of New York Mellon
BNY
$106B
| $214K | 0.04% |
4,839
+1
| +0% | +$47 |
|
189
Urban Outfitters
URBN
$6.35B
| $214K | 0.04% |
+9,400
| New | +$255K |
|
190
ResMed
RMD
$30.6B
| $201K | 0.04% |
+1,650
| New | +$183K |
|
191
Verizon
VZ
$195B
| $200K | 0.04% |
3,508
+8
| +0.2% | +$461 |
|
192
Sprott Physical Gold and Silver Trust
CEF
$7.4B
| $132K | 0.02% |
10,000
| – | – |
|
193
Arlo Technologies
ARLO
$1.6B
| – | – |
-22,198
| Closed | -$92K |
|
194
AudioCodes
AUDC
$244M
| – | – |
-81,900
| Closed | -$1.13M |
|
195
Bruker
BRKR
$9.57B
| – | – |
-10,730
| Closed | -$412K |
|
196
Clean Harbors
CLH
$16.5B
| – | – |
-3,600
| Closed | -$258K |
|
197
CNX Resources
CNX
$5.3B
| – | – |
-30,366
| Closed | -$327K |
|
|
CYBR
198
DELISTED
CyberArk
CYBR
| – | – |
-42,170
| Closed | -$5.02M |
|
|
DX
199
Dynex Capital
DX
$3.15B
| – | – |
-19,593
| Closed | -$358K |
|
200
First Commonwealth Financial
FCF
$2.18B
| – | – |
-60,300
| Closed | -$760K |
|
Similar funds
BG
DFO
VFCM
MCM
EFM
DIA
5NCM
QCG
Oberweis Asset Management's Q2 2019 Portfolio in Review
As of Q2 2019, Oberweis Asset Management held 230 positions worth $550M, up 11% from $498M the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Oberweis Asset Management deployed $19.4M of net new capital in Q2 2019, opening 29 new positions and adding to 85 existing holdings. Its largest new stake was uniQure: 442,900 shares worth $34.6M.
By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 28% a quarter earlier, followed by Consumer Staples and Technology.
On the sell side, the largest reduction was Ligand Pharmaceuticals, an estimated $4.83M trimmed.
- Oberweis Asset Management's largest Q2 2019 buy was uniQure: 442,900 shares worth $34.6M.
- Oberweis Asset Management added most to GW Pharmaceuticals Plc American Depositary Shares in Q2 2019, an estimated $47.5M increase.
- Oberweis Asset Management's biggest Q2 2019 reduction was Ligand Pharmaceuticals, cutting an estimated $4.83M.
- Oberweis Asset Management fully exited Mellanox Technologies, Ltd. in Q2 2019, selling an estimated $33.8M.
- Oberweis Asset Management's ten largest holdings make up 52% of its $550M portfolio in Q2 2019.
- Oberweis Asset Management opened 29 new positions and closed 34 in Q2 2019.
- Oberweis Asset Management's portfolio value rose 11% quarter-over-quarter to $550M.
Based on Oberweis Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.